The Patent Office announced Friday that the changes will focus the examination process on claims that contain more than one independent and distinct invention.
The proposed rules would change the current practice of listing multiple inventions in a single claim. So-called "multiinvention alternative" claims are extremely common in the pharmaceutical, chemical, and biotechnology industry, according to the Patent Office.
The new rules would require applicants to identify, with more specificity, the claimed invention to be examined. The office said that will promote better quality examinations.
The rules announced Friday are separate from recent final rules regarding claims and continuations. The claim and continuation rules are expected to be published in the Federal Register later this month. The proposed rules for examinations, announced Friday, are available in the Federal Register now (pdf).
The new rules are part of an ongoing federal effort to ensure patent quality, improve the examination process, and reduce the number of patents pending. Proposed patent changes have produced much debate, but people on all sides agree that examiners are overwhelmed by the sheer number of applications they receive.
The Patent Office will accept comments on the proposed rules, as well as further suggestions for changes to improve the examination of multi-invention alternative claims, until Oct. 9. The office doesn't plan to hold a hearing on the issue.
Stay connected and informed by visiting the CA Solutions Center Community!

Become a member today for instant access to free InformationWeek research, expert advice, peer perspectives, and more on the following topics:
- Application Performance Management (APM)
- Security Management
- Mainframe 2.0
- IT Automation
- Service Assurance
Also, visit our Government and Financial Services groups to see how these technologies apply specifically to those industries.
NOTE: Offer valid for U.S., U.S. possessions, & Canada only.